By rray, 31 October, 2023 Patient Type Header (Long) Older Adults (≥60 yo) Does this Patient Type contain sub types? No Patient Type Details ACIP recommends that people 60 yo receive a single dose of RSV vaccine using shared clinical decision making FDA has approved 2 vaccines for preventing RSV LRTI in this age group Although both vaccines are generally well tolerated w an acceptable safety profile 6 cases of inflammatory neurologic events Guillain Barr syndrome GBS acute disseminated encephalomyelitis ADEM and others were reported after RSV vaccination in clinical tr Timing Coadministration Precautions and Contradictions Report adverse events to the Vaccine Adverse Event Reporting System https vaers hhs gov index html or 1 800 822 7967